Randomized, sham-controlled trial: Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs.
7 Apr, 2022 | 09:49h | UTCLong-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial – The Lancet (link to abstract – $ for full-text)
Commentary: Three-year trial of SPYRAL HTN-ON MED shows blood pressure reductions – MedicalXpress
Related:
Commentary on Twitter
Renal denervation could provide an adjunctive treatment modality in the management of patients with #hypertension, suggests trial assessing long-term efficacy & safety in the presence of antihypertensive drugs: https://t.co/45ojbyhQp3 pic.twitter.com/eg6CXGDGCE
— The Lancet (@TheLancet) April 6, 2022